Full Text
Budget Impact Analysis of Crizotinib as Treatment of Anaplastic Lymphoma Kinase (ALK) Positive Advanced Nsclc in Panama

Abstract

Authors

M. Garita M. Peralta R.I. Lopez

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×